Control of NAD+ homeostasis by autophagic flux modulates mitochondrial and cardiac function
Ontology highlight
ABSTRACT: Impaired autophagy is known to cause mitochondrial dysfunction and heart failure, in part due to altered mitophagy and protein quality control. However, whether additional mechanisms are involved in the development of mitochondrial dysfunction and heart failure in the setting of deficient autophagic flux remains poorly explored. Here, we show that impaired autophagic flux reduces nicotinamide adenine dinucleotide (NAD+) availability in cardiomyocytes. NAD+ deficiency upon autophagic impairment is attributable to induction of nicotinamide N-methyltransferase (NNMT), which methylates the NAD+ precursor nicotinamide (NAM) to generate N-methyl-nicotinamide (MeNAM). The administration of nicotinamide mononucleotide (NMN) or inhibition of NNMT activity in autophagy-deficient hearts and cardiomyocytes restores NAD+ levels and ameliorates cardiac and mitochondrial dysfunction. Mechanistically, autophagic inhibition causes accumulation of SQSTM1, which activates NF-kB signaling and promotes NNMT transcription. In summary, we describe a novel mechanism illustrating how autophagic flux maintains mitochondrial and cardiac function by mediating SQSTM1-NF-kB-NNMT signaling and controlling the cellular levels of NAD+.
SUBMITTER: Dr. quanjiang zhang
PROVIDER: S-SCDT-10_1038-S44318-023-00009-W | biostudies-other |
REPOSITORIES: biostudies-other
ACCESS DATA